NCT05428852
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years to 75 Years (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must be scheduled to receive stereotactic radiosurgery (SRS)
Exclusions: Patients with previous or suspected leptomeningeal disease
https://ClinicalTrials.gov/show/NCT05428852